Insider Transactions in Q4 2021 at Cerus Corp (CERS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Gail Schulze Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.36%
|
$75,000
$3.19 P/Share
|
|
Dec 17
2021
|
Laurence M Corash Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.25%
|
$15,000
$3.75 P/Share
|
|
Dec 13
2021
|
Laurence M Corash Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+1.94%
|
$120,000
$3.75 P/Share
|
|
Nov 09
2021
|
Gail Schulze Director |
SELL
Open market or private sale
|
Direct |
25,000
-47.07%
|
$175,000
$7.54 P/Share
|
|
Nov 09
2021
|
Gail Schulze Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.0%
|
$50,000
$2.86 P/Share
|
|
Nov 05
2021
|
Carol Moore SVP Reg. & Quality |
SELL
Open market or private sale
|
Direct |
110,000
-37.76%
|
$770,000
$7.94 P/Share
|
|
Nov 05
2021
|
Carol Moore SVP Reg. & Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+27.53%
|
$330,000
$3.75 P/Share
|
|
Nov 03
2021
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
165,000
-38.9%
|
$1,155,000
$7.53 P/Share
|
|
Nov 03
2021
|
Richard J Benjamin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
165,000
+27.44%
|
$660,000
$4.46 P/Share
|
|
Nov 03
2021
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
95,741
-20.63%
|
$670,187
$7.0 P/Share
|
|
Nov 03
2021
|
Kevin Dennis Green Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+27.64%
|
$285,000
$3.75 P/Share
|
|
Nov 03
2021
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
40,000
-37.37%
|
$280,000
$7.7 P/Share
|